Skip to main content
. 2021 Apr 27;28(3):1630–1640. doi: 10.3390/curroncol28030152

Figure 3.

Figure 3

Comparison of survival parameters PFS (above) and OS (below) with patients with a complete metabolic remission (CMR) versus patients with residual disease or non-complete metabolic remission (nonCMR) and a stable or decreased total metabolic tumor volume (TMTV) on follow-up PET/CT 2–4 months after baseline PET/CT.